Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Chubb
Healthtrust
Johnson and Johnson
Argus Health
Novartis
Farmers Insurance
Accenture
Citi

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,461,031

« Back to Dashboard

Summary for Patent: 5,461,031
Title: Monomeric insulin analog formulations
Abstract:The present invention discloses various parenteral pharmaceutical formulations, which comprise: a monomeric insulin analog, zinc, protamine, and phenolic derivative. The analog formulations provide a prolonged duration of action. A process for preparing insulin analog-protamine formulations is also described.
Inventor(s): De Felippis; Michael R. (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:08/260,633
Patent Claim Types:
see list of patent claims
Formulation; Process; Use;

Drugs Protected by US Patent 5,461,031

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,461,031

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hungary 9501717 ➤ Subscribe
Greece 1002494 ➤ Subscribe
China 1145641 ➤ Subscribe
Colombia 4410204 ➤ Subscribe
Czech Republic 9501543 ➤ Subscribe
Czech Republic 294556 ➤ Subscribe
Germany 19521753 ➤ Subscribe
Denmark 67695 ➤ Subscribe
Denmark 176213 ➤ Subscribe
Spain 2091728 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Healthtrust
Deloitte
Cipla
UBS
Federal Trade Commission
Cerilliant
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot